Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac
- PMID: 38162695
- PMCID: PMC10755768
- DOI: 10.1016/j.tipsro.2023.100224
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac
Abstract
Background and purpose: Online adaptive MR-guided radiotherapy (MRgRT) is a relatively new form of radiotherapy treatment, delivered using a MR-Linac. It is unknown what patients expect from this treatment and whether these expectations are met. This study evaluates whether patients' pre-treatment expectations of MRgRT are met and reports patients' on-table experience on a 1.5 T MR-Linac.
Materials and methods: All patients treated on the MR-Linac from November 2020 until April 2021, were eligible for inclusion. Patient expectation and experience were captured through questionnaires before, during, and three months after treatment. The on-table experience questionnaire included patient' physical and psychological coping. Patient-expected side effects, participation in daily and social activity, disease outcome and, disease related symptoms were compared to post-treatment experience.
Results: We included 113 patients who were primarily male (n = 100, 89 %), with a median age of 69 years (range 52-90). For on-table experience, ninety percent of patients (strongly) agreed to feeling calm during their treatment. Six and eight percent of patients found the treatment position or bed uncomfortable respectively. Twenty-eight percent of patients felt tingling sensations during treatment. After treatment, 79 % of patients' expectations were met. Most patients experienced an (better than) expected level of side effects (75 %), participation in daily- (83 %) and social activity (86 %) and symptoms (78 %). However, 33 % expected more treatment efficacy than experienced.
Conclusion: Treatment on the 1.5 T MR-Linac is well tolerated and meets patient expectations. Despite the fact that some patients expected greater treatment efficacy and the frequent occurrence of tingling sensations during treatment, most patient experiences were comparable or better than previously expected.
Keywords: MR-Linac; MRgRT; Patient reported experience measures (PREM); Patient reported outcomes.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.Cureus. 2019 Dec 24;11(12):e6457. doi: 10.7759/cureus.6457. Cureus. 2019. PMID: 32025388 Free PMC article.
-
Online adaptive MR-guided radiotherapy for rectal cancer; feasibility of the workflow on a 1.5T MR-linac: clinical implementation and initial experience.Radiother Oncol. 2021 Jan;154:172-178. doi: 10.1016/j.radonc.2020.09.024. Epub 2020 Sep 22. Radiother Oncol. 2021. PMID: 32976875
-
Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.Radiother Oncol. 2020 May;146:118-125. doi: 10.1016/j.radonc.2020.02.011. Epub 2020 Mar 6. Radiother Oncol. 2020. PMID: 32146257
-
Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.Front Endocrinol (Lausanne). 2023 May 26;14:994370. doi: 10.3389/fendo.2023.994370. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37305036 Free PMC article.
-
[Primary treatment of prostate cancer using 1.5 T MR-linear accelerator].Radiologe. 2021 Sep;61(9):839-845. doi: 10.1007/s00117-021-00882-8. Epub 2021 Jul 23. Radiologe. 2021. PMID: 34297139 Free PMC article. Review. German.
Cited by
-
On Patient Experience and Anxiety During Treatment With Magnetic Resonance-Guided Radiation Therapy.Adv Radiat Oncol. 2024 May 4;9(8):101537. doi: 10.1016/j.adro.2024.101537. eCollection 2024 Aug. Adv Radiat Oncol. 2024. PMID: 39035171 Free PMC article.
References
-
- Ferlay J, Ervik M, Lam F, Colombet M, Mery LPM. Global cancer observatory: cancer today. Lyon: International Agency for Research on Cancer. Int. Agent Res. Cancer - WHO 419, 199–200; 2020.
-
- Goldberg P.A., Nicholls R.J., Porter N.H., Love S., Grimsey J.E. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failure. Eur J Cancer. 1994;30:1602–1606. - PubMed
-
- Miller K.D., et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–385. - PubMed
-
- Lesueur P., et al. Definition of accurate planning target volume margins for esophageal cancer radiotherapy. Cancer/Radiotherapie. 2016;20:651–656. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous